The grant from a prestigious foundation like the Bill & Melinda Gates Foundation not only provides financial support but also adds significant credibility to Ginkgo Bioworks' project. This partnership is likely to positively influence investor perception, potentially leading to an increase in stock price in the short term. The focus on AI and public health could also align with current investment trends favoring technology and healthcare innovation.